Eco survey: health expenditure increased from 29% to 48% between 2015-2022 - the statesman

Initiatives by the government, including preventive measures, universal access to high-quality healthcare, strengthened public health infrastructure, and advancements in medical education,

have collectively contributed to making healthcare in India more accessible and affordable for all, according to the Economic Survey 2024-25 tabled in Parliament on Friday. India’s economic

growth strategy emphasises inclusivity and welfare for all its citizens. The government’s focus is on empowering citizens through education, healthcare, skill development, and social

infrastructure development. Inclusive economic growth is central to the vision of ‘Viksit Bharat’ 2047, said the Survey tablede by Union Finance Minister Nirmala Sitharaman. Advertisement As

per the Economic Survey, the Total Health Expenditure (THE) in FY22 is estimated to be Rs 9,04,461 crore (3.8 per cent of GDP and Rs 6,602 per capita at current prices). Total Health

Expenditure per capita (at constant prices) has shown an increasing trend since FY19. Advertisement In the total health expenditure of the country between FY15 and FY22, the share of

government health expenditure has increased from 29.0 per cent to 48.0 per cent. The current health expenditure (CHE) is Rs 7,89,760 crore (87.3 percent of THE), and capital expenditure is

Rs 1,14,701 crore (12.7 percent of THE). An increase in the share of capital expenditure in THE from 6.3 per cent in FY16 to 12.7 percent in FY22 is a positive sign as it will lead to

broader and better health infrastructure. The AB-PMJAY has revolutionised healthcare by providing health coverage to the bottom 40 per cent of India’s most vulnerable populations. The

increase in government spending on health has an important implication for the reduction of financial hardship endured by households. As of 15 January 2025, more than 40 lakh senior citizens

have been enrolled in the scheme. AB-PMJAY has played a decisive role in the significant reductions observed in Out-of-pocket expenditure (OOPE) through an increase in social security and

primary health expenditure, with over ₹1.25 lakh crore in savings recorded. Other initiatives, such as the Free Dialysis scheme, have benefited around 25 lakh people. The reduction in OOPE

goes hand in-hand with increased public spending in healthcare, demonstrating progress towards universal health coverage. Under the scheme, by transforming sub-health centres (SHCs) and

primary health centres (PHCs), Ayushman Arogya Mandirs (AAM) (formerly Health & Wellness Centres) have been operationalised, in rural and urban areas, offering a universal, free, and

expanded package of preventive, promotive, curative, palliative, and rehabilitative services closer to communities. The Economic Survey has highlighted that under Ayushman Bharat Digital

Mission (ABDM) 72.81 crore Ayushman Bharat health Accounts have been created. It has also highlighted that E-Sanjeevani – the National Telemedicine Service, has emerged as the world’s

largest telemedicine implementation in primary healthcare. It has served over 31.19 crore patients through 1.29 lakh AAM as spokes, which are served by 16,447 hubs and 676 online OPDs. The

Economic Survey further stated that on the U –WIN portal over 1.7 crore pregnant women and 5.4 crore children have registered digitally and tracked more than 26.4 crore vaccine doses in

real-time. The Economic Survey points out that Drones are transforming healthcare in India by ensuring rapid delivery of life-saving medicines and collecting samples from remote and

inaccessible areas, proving indispensable during emergencies. The Survey says that India has great potential in Artificial Intelligence adoption in Healthcare. It also stated that in 2023,

34 percent of healthcare organisations in India were piloting AI projects, and 16 per cent had moved their generative AI initiatives into production. The Survey also states that the Jan

Aushadhi scheme, launched to provide affordable medicines, has improved access to low-cost drugs achieving record sales in 2024 and expanding to over 14,000 kendras nationwide. Advertisement